Raymond P Tucker1, Rylan J Testa2, Tracy L Simpson3, Jillian C Shipherd4, John R Blosnich5, Keren Lehavot3. 1. Louisiana State University,Baton Rouge,LA,USA. 2. Rhodes College,Memphis,TN,USA. 3. VA Puget Sound Health Care System,Seattle,WA,USA. 4. National Center for PTSD,VA Boston Healthcare System,Boston University,Veterans Health Administration. 5. Center for Health Equity Research and Promotion,VA Pittsburgh Healthcare System,Pittsburgh,PA,USA.
Abstract
BACKGROUND: Access to transition-related medical interventions (TRMIs) for transgender veterans has been the subject of substantial public interest and debate. To better inform these important conversations, the current study investigated whether undergoing hormone or surgical transition intervention(s) relates to the frequency of recent suicidal ideation (SI) and symptoms of depression in transgender veterans. METHODS: This study included a cross-sectional, national sample of 206 self-identified transgender veterans. They self-reported basic demographics, TRMI history, recent SI, and symptoms of depression through an online survey. RESULTS: Significantly lower levels of SI experienced in the past year and 2-weeks were seen in veterans with a history of both hormone intervention and surgery on both the chest and genitals in comparison with those who endorsed a history of no medical intervention, history of hormone therapy but no surgical intervention, and those with a history of hormone therapy and surgery on either (but not both) the chest or genitals when controlling for sample demographics (e.g., gender identity and annual income). Indirect effect analyses indicated that lower depressive symptoms experienced in the last 2-weeks mediated the relationship between the history of surgery on both chest and genitals and SI in the last 2-weeks. CONCLUSIONS: Results indicate the potential protective effect that TRMI may have on symptoms of depression and SI in transgender veterans, particularly when both genitals and chest are affirmed with one's gender identity. Implications for policymakers, providers, and researchers are discussed.
BACKGROUND: Access to transition-related medical interventions (TRMIs) for transgender veterans has been the subject of substantial public interest and debate. To better inform these important conversations, the current study investigated whether undergoing hormone or surgical transition intervention(s) relates to the frequency of recent suicidal ideation (SI) and symptoms of depression in transgender veterans. METHODS: This study included a cross-sectional, national sample of 206 self-identified transgender veterans. They self-reported basic demographics, TRMI history, recent SI, and symptoms of depression through an online survey. RESULTS: Significantly lower levels of SI experienced in the past year and 2-weeks were seen in veterans with a history of both hormone intervention and surgery on both the chest and genitals in comparison with those who endorsed a history of no medical intervention, history of hormone therapy but no surgical intervention, and those with a history of hormone therapy and surgery on either (but not both) the chest or genitals when controlling for sample demographics (e.g., gender identity and annual income). Indirect effect analyses indicated that lower depressive symptoms experienced in the last 2-weeks mediated the relationship between the history of surgery on both chest and genitals and SI in the last 2-weeks. CONCLUSIONS: Results indicate the potential protective effect that TRMI may have on symptoms of depression and SI in transgender veterans, particularly when both genitals and chest are affirmed with one's gender identity. Implications for policymakers, providers, and researchers are discussed.
Authors: Ana M Progovac; Brian O Mullin; Emilia Dunham; Sari L Reisner; Alex McDowell; Maria Jose Sanchez Roman; Mason Dunn; Cynthia J Telingator; Frederick Q Lu; Aaron Samuel Breslow; Marshall Forstein; Benjamin Lê Cook Journal: Am J Prev Med Date: 2020-03-07 Impact factor: 5.043
Authors: Ryan M Surmaitis; Marna Rayl Greenberg; Natalie E Ebeling-Koning; Phillip M Grenz; Cody R McWhirter; Beth A Careyva; Judith N Sabino; Matthew D Cook; Robert D Cannon; Andrew L Koons; Kenneth D Katz; Hope Kincaid; Lexis T Laubach; Gillian A Beauchamp Journal: J Med Toxicol Date: 2020-06-17
Authors: Maiko A Schneider; Poli M Spritzer; Luciano Minuzzi; Benicio N Frey; Sabrina K Syan; Tayane M Fighera; Karine Schwarz; Ângelo B Costa; Dhiordan C da Silva; Cláudia C G Garcia; Anna M V Fontanari; André G Real; Maurício Anes; Juliana U Castan; Fernanda R Cunegatto; Maria I R Lobato Journal: Front Neurosci Date: 2019-08-07 Impact factor: 4.677
Authors: Jack Andrzejewski; Richard Dunville; Michelle M Johns; Stuart Michaels; Sari L Reisner Journal: LGBT Health Date: 2021-02-09 Impact factor: 4.151
Authors: Lovro Markovic; Daragh T McDermott; Sinisa Stefanac; Radhika Seiler-Ramadas; Darina Iabloncsik; Lee Smith; Lin Yang; Kathrin Kirchheiner; Richard Crevenna; Igor Grabovac Journal: Int J Environ Res Public Health Date: 2021-06-27 Impact factor: 3.390